Almonty's Sangdong Awakening: Production Starts as Insiders Sell $227 Million in Shares
Published on 07/14/2026 at 07:11 | Redaktion boerse-global.de
On July 1, Almonty Industries crossed a critical threshold: the Sangdong tungsten mine in South Korea began churning out saleable concentrate, officially transforming the project developer into a certified producer. Yet what should have been a moment of unalloyed triumph arrived alongside an extraordinary wave of insider selling that has left investors wrestling with contradictory signals. Over the past 90 days, directors and top executives have unloaded a net $227.6 million worth of stock, with $75.1 million of that total coming directly from company officers. Director Mark Trachuk alone sold 200,000 shares at C$24.07 on July 2, pocketing roughly C$4.8 million.
The market's response to Sangdong's debut has been characteristically whipsawed. In New York, the stock surged nearly 11% on July 10 to $14.70, while Toronto-listed shares climbed 12.4% to C$23.38. The gains proved short-lived. A few days later, the Nasdaq-traded stock fell 6.7% to $15.52 on unusually thin volume — just 1.1 million shares, 79% below the average — suggesting a few large orders drove the move. Over the past month, the stock has lost nearly 15%, and the C$21.37 close in Toronto sits 36% below the 52-week high of C$33.35 reached in April. The annualized 30-day volatility has soared to nearly 100%, a measure of just how unsettled the trading has become.
The insider exodus is all the more striking because it coincides with what should be a fundamentally bullish chapter. Almonty is now processing a surface stockpile of roughly 139,700 metric tons of ore carrying tungsten oxide grades between 0.24% and 0.35%, with an estimated gross value of $68 million. The company plans to use an initial 2.6-month period to stabilize plant operations before ramping up to continuous full production of 4,600 tons of tungsten concentrate per year. The long-term thesis is reinforced by high tungsten prices and Western efforts to reduce dependence on Chinese supply — a narrative given further weight when the Plansee Group, a major shareholder, confirmed a long-term offtake agreement with Sangdong in its own recent financial results.
Should investors sell immediately? Or is it worth buying Almonty?
Wall Street analysts have largely shrugged off the insider selling and trained their attention on the operational story. DA Davidson raised its price target from $25 to $33 with a Buy rating, B. Riley Financial lifted its target from $17 to $23, and Oppenheimer bumped its target to $25 with an Outperform call. Bank of America Securities reiterated its Buy recommendation, and a virtual investor meeting with CEO Lewis Black reportedly bolstered confidence in the Sangdong ramp-up, potential US government collaboration, and the company's solid liquidity. Among the six analysts covering the stock, the consensus is Moderate Buy with an average price target of $21.88, roughly where the Toronto-traded shares currently sit. Weiss Ratings stands as the lone dissenter, maintaining a Sell (D-) rating.
The balance sheet received a significant reinforcement in June, when Almonty placed convertible notes carrying a 2.25% coupon and maturing in 2031. Underwriters fully exercised their overallotment option, pushing total proceeds to $800 million. Net proceeds of roughly $772.7 million are earmarked for debt refinancing and balance-sheet strengthening, providing financial ballast during the mine's ramp-up phase. The initial conversion price of approximately $27.40 per share sits well above the current trading level, offering some reassurance that near-term dilution is not imminent. Meanwhile, institutional investors have been building positions at a remarkable pace. Van Eck Associates increased its stake by 13,294.7% in the fourth quarter and now holds roughly 11.2 million shares worth nearly $99 million. Cooper Creek Partners Management raised its position by 110.4% to about $69 million, and Encompass Capital Advisors added 47.9% to reach approximately $62 million. Those purchases occurred as Almonty hit its operational milestones and were followed by inclusion in the Russell 1000 and Russell 3000 indices — events that have added fuel to the price swings.
On a technical basis, the stock is in a correction but not yet oversold. The 14-day Relative Strength Index of 41.3 is approaching the oversold threshold of 30 but has not crossed it. The shares trade about 15% below their 50-day moving average of C$25.24 and roughly 14% above the 200-day average of C$18.76. Despite the recent pullback, the longer-term gains remain staggering: the stock is up about 78% year-to-date and more than 227% over the past twelve months. At a market capitalization of roughly €4.1 billion, Almonty carries a negative price-to-earnings ratio of -30.03, underscoring that profitability remains elusive. Its quick ratio of 2.37 and current ratio of 2.45, however, point to ample liquidity to navigate the ramp-up.
The central tension at Almonty is laid bare: the company is executing on its core thesis — turning Sangdong into a producing asset capable of helping Western supply chains decouple from China — even as its own leaders take substantial profits. For outside investors, the question is whether the insider selling reflects a sobering view of the stock's valuation or simply rational harvesting of gains from a share price that has more than quintupled since its 52-week low of C$4.36. The market, caught between those two narratives, has responded with extremes of volatility, and the resolution will likely come only as Sangdong's production data fills in over the months ahead.
Ad
Almonty Stock: New Analysis - 14 July
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
